![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Objective. Little is known about the expression of stem cell markers in normal liver and colorectal liver metastases (CLM). The aim of this paper is to assess whether patterns of stem cell marker expression differ between normal liver tissue and CLM and to determine whether a clinical model of liver regeneration induced by portal vein embolization (PVE) has any influence on these patterns of expression in both regenerated liver tissue and cancer. Materials and methods. Immunohistochemistry was used to provide semi-quantitative analysis of patterns of expression in tissue samples of liver and tumor tissue pre- and post-PVE in 23 patients with CLM. CD133, CD44 and Oct4 were studied. Results. There was no expression of CD133, CD44 or Oct4 in normal liver tissue before PVE but there was high expression of CD133 and CD44 in CLM. PVE had no significant influence on stem cell marker expression either in regenerated liver tissue or in tumor when compared with pre-PVE samples. Conclusion. Liver regeneration following PVE does not seem to involve stem cells. Stem cell marker expression by CLM supports the stem cell theory of carcinogenesis which is not influenced by PVE.
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.